Methamphetamine use has increased over the past 15 years, with corresponding increases
in associated morbidity and mortality. Toxicities from methamphetamine use largely consist …

We assessed the association between the use of medications for attention-
deficit/hyperactivity disorder (ADHD) and the risk of all-cause mortality and unintentional …

Background: Preliminary evidence suggest clozapine is associated with more favorable
impact on concurrent substance use disorder related outcomes in patients with concurrent …

Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction,
including interventions that focus on prescribing pharmaceutical-grade psychoactive …

• Accumulating evidence supports treatment of stimulant use disorder with prescribed
psychostimulants, but no pharmacologic treatments for stimulant use disorder are currently …

Background Cluster B personality disorders (PDs) are considered some of the most severe
mental health conditions. Scarce evidence exists about the real-world utilization of …

Background Attention-deficit and hyperactivity disorder (ADHD) is frequently diagnosed in
patients with substance use disorders (SUDs), including opioids. There remains concern …

While attention deficit hyperactivity disorder is common among people with addiction, the
risks and benefits of attention deficit hyperactivity disorder medication in pregnant people …

By the importance of developing detection materials and devices, the current work was done
to provide molecular insights into the exploration of amphetamine (AMP) …

Importance Individuals with attention-deficit/hyperactivity disorder (ADHD) often have
comorbid psychiatric conditions. Relatively little is known about how specific ADHD …